Ycanth 0.7 % Topical Solution
- RxCUI
- 2643442
- RxNorm name
- Ycanth 0.7 % Topical Solution
- Display name
- Ycanth 0.7 % Topical Solution
- Full name
- Ycanth 0.7 % Topical Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| YCANTH | CANTHARIDIN | Verrica Pharmaceuticals Inc. | 7c9bdeaa-9822-4c69-a719-ea4a8643f59c | 2024-11-13 | Warnings, Adverse reactions | 2643442 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7c9bdeaa-9822-4c69-a719-ea4a8643f59c | Ycanth 0.7 % Topical Solution [PSN] · cantharidin 7 MG/ML Topical Solution [Ycanth] [SBD] · Ycanth 0.7 % Topical Solution [SY] · Ycanth 7 MG/ML Topical Solution [SY] | 4 | 4 | These highlights do not include all the information needed to use YCANTH safely and effectively. See full prescribing information for YCANTH. YCANTH ® (cantharidin) topical solution Initial U.S. Approval: 2023 | 20241113 |